EUVIMEDEUVIMED entdecken
Crossref

EFFICACY AND SAFETY OF INTRAVENOUS ILOPROST IN THE TREATMENT OF RAYNAUD’S PHENOMENON AND DIGITAL ULCERS IN PATIENT WITH SYSTEMIC SCLERODERMA

Hoa Nguyen Thi, Doanh Le Huu, Hien Do Thi Thu, Phuong Hoang Thi, Thuy Nguyen Thi Thanh

Tạp chí Da liễu học Việt Nam · 2023

DOI: 10.56320/tcdlhvn.36.70 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tạp chí Da liễu học Việt Nam, 2023. Verfasst von Hoa Nguyen Thi und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the efficacy and safety of intravenous iloprost in the treatment of Raynaud’s phenomenon and digital ulcers in patients with SSc (systemic scleroderma).

Methods

31 patients with SSc were treated with intravenous iloprost in NHDV from April, 2017 to March, 2020. Evaluation was done after 2 weeks and included: width of ulcer, depth of ulcer, Raynaud phenomenon, laboratory tests, drug side effects.

Results

VAS of Raynaud’s syndrome decreased markedly after iloprost infusion, from 71.5 points to 36.9 points. (p < 0.001). The depth of ulcer improved markedly after 2 weeks of treatment, the rate of deep ulcers decreased from 20.6% to 1% (p < 0.001). The ulcer width improved significantly after 2 weeks of treatment, the rate of grade 3 ulcers decreased from 35.1% to 13.4% (p < 0.001). Side effects were found in 38.7% of patients, mainly headache (25.7%), flushing (9.7%); nausea/vomiting (6.5%); reaction at the site of infusion (6.5%). All side effects disappear when the infusion rate reduced. The majority of patients tolerated the drug at the maximum infusion rate (level 4), accounted for 61.3%.

Conclusion

Intravenous iloprost is an effective and safe drug in the treatment of Raynaud’s phenomenon and digital ulcers in patients with SSc. The infusion process should be monitored according to the instructions.

Zitieren

APA

Thi, H. N., Huu, D. L., Thu, H. D. T., Thi, P. H., & Thanh, T. N. T. (2023). EFFICACY AND SAFETY OF INTRAVENOUS ILOPROST IN THE TREATMENT OF RAYNAUD’S PHENOMENON AND DIGITAL ULCERS IN PATIENT WITH SYSTEMIC SCLERODERMA. Tạp chí Da liễu học Việt Nam. https://doi.org/10.56320/tcdlhvn.36.70

Vancouver

Thi HN, Huu DL, Thu HDT, Thi PH, Thanh TNT. EFFICACY AND SAFETY OF INTRAVENOUS ILOPROST IN THE TREATMENT OF RAYNAUD’S PHENOMENON AND DIGITAL ULCERS IN PATIENT WITH SYSTEMIC SCLERODERMA. Tạp chí Da liễu học Việt Nam. 2023. doi:10.56320/tcdlhvn.36.70

BibTeX
@article{Thi2023,
  author = {Thi, Hoa Nguyen and Huu, Doanh Le and Thu, Hien Do Thi and Thi, Phuong Hoang and Thanh, Thuy Nguyen Thi},
  title = {EFFICACY AND SAFETY OF INTRAVENOUS ILOPROST IN THE TREATMENT OF RAYNAUD’S PHENOMENON AND DIGITAL ULCERS IN PATIENT WITH SYSTEMIC SCLERODERMA},
  journal = {Tạp chí Da liễu học Việt Nam},
  year = {2023},
  doi = {10.56320/tcdlhvn.36.70}
}
Kostenlos starten →